ARTICLE | Clinical News
SinuNase: Phase III start
April 17, 2006 7:00 AM UTC
ABPI will begin this half a 4-month, double-blind, placebo-controlled, U.S. Phase III study in 200 to 300 post-surgical patients suffering from recurrent chronic sinusitis. ...